{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T23:20:02Z","timestamp":1770074402343,"version":"3.49.0"},"publisher-location":"Cham","reference-count":134,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030639075","type":"print"},{"value":"9783030639082","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-63908-2_2","type":"book-chapter","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T19:04:49Z","timestamp":1620327889000},"page":"13-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Kidney Diseases: The Age of Molecular Markers"],"prefix":"10.1007","author":[{"given":"Glaucia Luciano","family":"da Veiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"da Costa Aguiar Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus Moreira","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce Regina","family":"Raimundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9ssica Freitas","family":"de Ara\u00fajo Encinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neif","family":"Murad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Luiz Affonso","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.cca.2014.08.039","volume":"438","author":"ME Wasung","year":"2015","unstructured":"Wasung, M.E., Chawla, L.S., Madero, M.: Biomarkers of renal function, which and when? Clin. Chim. Acta. 438, 350\u2013357 (2015)","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"2_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/02701367.1981.10607881","volume":"52","author":"WW Riley","year":"1981","unstructured":"Riley, W.W., Powers, S.K., Welch, H.G.: The effect of two levels of muscular work on urinary creatinine excretion. Res. Q. Exerc. Sport. 52(3), 339\u2013347 (1981)","journal-title":"Res. Q. Exerc. Sport"},{"issue":"4","key":"2_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.ajkd.2012.10.017","volume":"61","author":"SP Juraschek","year":"2013","unstructured":"Juraschek, S.P., Appel, L.J., Anderson, C.A., Miller, E.R.: Effect of a high-protein diet on kidney function in healthy adults: results from the OmniHeart trial. Am. J. Kidney Dis. 61(4), 547\u2013554 (2013)","journal-title":"Am. J. Kidney Dis."},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/bs.acc.2018.10.005","volume":"88","author":"JA George","year":"2019","unstructured":"George, J.A., Gounden, V.: Novel glomerular filtration markers. Adv. Clin. Chem. 88, 91\u2013119 (2019)","journal-title":"Adv. Clin. Chem."},{"issue":"1","key":"2_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","volume":"62","author":"WK Han","year":"2002","unstructured":"Han, W.K., Bailly, V., Abichandani, R., Thadhani, R., Bonventre, J.V.: Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62(1), 237\u2013244 (2002)","journal-title":"Kidney Int."},{"issue":"2","key":"2_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1517\/17530059.2011.552496","volume":"5","author":"J Fontanilla","year":"2011","unstructured":"Fontanilla, J., Han, W.K.: Kidney injury molecule-1 as an early detection tool for acute kidney injury and other kidney diseases. Expert Opin Med Diagn. 5(2), 161\u2013173 (2011)","journal-title":"Expert Opin Med Diagn."},{"issue":"3","key":"2_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf, R.M.: Biomarker definitions and their applications. Exp. Biol. Med. (Maywood). 243(3), 213\u2013221 (2018)","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"1","key":"2_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0300985813505117","volume":"51","author":"VG Sasseville","year":"2014","unstructured":"Sasseville, V.G., Mansfield, K.G., Brees, D.J.: Safety biomarkers in preclinical development: translational potential. Vet. Pathol. 51(1), 281\u2013291 (2014)","journal-title":"Vet. Pathol."},{"key":"2_CR9","doi-asserted-by":"crossref","unstructured":"Aronson, J.K., Ferner, R.E.: Biomarkers \u2013 a general review. Curr Protoc Pharmacol. 76, 9.23.1\u20139.23.17 (2017)","DOI":"10.1002\/cpph.19"},{"issue":"3","key":"2_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/1535370217733425","volume":"243","author":"DF Carr","year":"2018","unstructured":"Carr, D.F., Pirmohamed, M.: Biomarkers of adverse drug reactions. Exp. Biol. Med. (Maywood). 243(3), 291\u2013299 (2018)","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"11","key":"2_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2005.09.007","volume":"11","author":"SR Patel","year":"2005","unstructured":"Patel, S.R., Dressler, G.R.: BMP7 signaling in renal development and disease. Trends Mol. Med. 11(11), 512\u2013518 (2005)","journal-title":"Trends Mol. Med."},{"issue":"10","key":"2_CR12","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.4103\/0366-6999.181957","volume":"129","author":"L Zhang","year":"2016","unstructured":"Zhang, L., Li, X.S., Zhou, L.Q.: Renal tumor biopsy technique. Chin. Med. J. 129(10), 1236\u20131240 (2016)","journal-title":"Chin. Med. J."},{"key":"2_CR13","doi-asserted-by":"crossref","unstructured":"Pantel, K., Alix-Panabi\u00e8res, C.: Liquid biopsy and minimal residual disease \u2013 latest advances and implications for cure. Nat. Rev. Clin. Oncol. 16(7), 409\u2013424 (2019)","DOI":"10.1038\/s41571-019-0187-3"},{"issue":"2","key":"2_CR14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s13277-012-0634-6","volume":"34","author":"PO Delgado","year":"2013","unstructured":"Delgado, P.O., Alves, B.C., Gehrke, F.S., Kuniyoshi, R.K., Wroclavski, M.L., Del Giglio, A., et al.: Characterization of cell-free circulating DNA in plasma in patients with prostate cancer. Tumour Biol. 34(2), 983\u2013986 (2013)","journal-title":"Tumour Biol."},{"issue":"4","key":"2_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/gtmb.2018.0189","volume":"23","author":"S Jain","year":"2019","unstructured":"Jain, S., Lin, S.Y., Song, W., Su, Y.H.: Urine-based liquid biopsy for nonurological cancers. Genet. Test. Mol. Biomarkers. 23(4), 277\u2013283 (2019)","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"4","key":"2_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/pmic.200401012","volume":"5","author":"V Thongboonkerd","year":"2005","unstructured":"Thongboonkerd, V., Malasit, P.: Renal and urinary proteomics: current applications and challenges. Proteomics. 5(4), 1033\u20131042 (2005)","journal-title":"Proteomics"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4939-8973-7_15","volume":"1909","author":"S Salvi","year":"2019","unstructured":"Salvi, S., Casadio, V.: Urinary cell-free DNA: potential and applications. Methods Mol. Biol. 1909, 201\u2013209 (2019)","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"2_CR18","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1038\/s41467-018-04745-0","volume":"9","author":"P Burnham","year":"2018","unstructured":"Burnham, P., Dadhania, D., Heyang, M., Chen, F., Westblade, L.F., Suthanthiran, M., et al.: Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract. Nat. Commun. 9(1), 2412 (2018)","journal-title":"Nat. Commun."},{"issue":"1\u20133","key":"2_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0300-483X(94)90163-5","volume":"92","author":"AD Le Lann","year":"1994","unstructured":"Le Lann, A.D., Bret, L.C., Delverdier, M.E., Amardeilh, M.F., Alary, C., Fourni\u00e9, G.J.: Urinary DNA as an indicator of nephrotoxicity caused by endotoxin and gentamicin in mice. Toxicology. 92(1\u20133), 1\u201310 (1994)","journal-title":"Toxicology"},{"issue":"4","key":"2_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/j.ajkd.2005.12.027","volume":"47","author":"CC Szeto","year":"2006","unstructured":"Szeto, C.C., Chow, K.M., Lai, K.B., Szeto, C.Y., Chan, R.W., Kwan, B.C., et al.: mRNA expression of target genes in the urinary sediment as a noninvasive prognostic indicator of CKD. Am. J. Kidney Dis. 47(4), 578\u2013586 (2006)","journal-title":"Am. J. Kidney Dis."},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12885-016-2127-2","volume":"16","author":"L Mengual","year":"2016","unstructured":"Mengual, L., Lozano, J.J., Ingelmo-Torres, M., Izquierdo, L., Musquera, M., Ribal, M.J., et al.: Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers. BMC Cancer. 16, 76 (2016)","journal-title":"BMC Cancer"},{"issue":"9","key":"2_CR22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/sj.ki.5002729","volume":"73","author":"SG Coca","year":"2008","unstructured":"Coca, S.G., Yalavarthy, R., Concato, J., Parikh, C.R.: Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 73(9), 1008\u20131016 (2008)","journal-title":"Kidney Int."},{"issue":"5","key":"2_CR23","doi-asserted-by":"publisher","first-page":"R234","DOI":"10.1186\/cc13057","volume":"17","author":"J Vanmassenhove","year":"2013","unstructured":"Vanmassenhove, J., Glorieux, G., Hoste, E., Dhondt, A., Vanholder, R., Van Biesen, W.: Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis. Crit. Care. 17(5), R234 (2013)","journal-title":"Crit. Care"},{"issue":"1","key":"2_CR24","first-page":"33","volume":"108","author":"R Khanna","year":"2011","unstructured":"Khanna, R.: Clinical presentation & management of glomerular diseases: hematuria, nephritic & nephrotic syndrome. Mo Med. 108(1), 33\u201336 (2011)","journal-title":"Mo Med."},{"issue":"2","key":"2_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"AB Fogo","year":"2015","unstructured":"Fogo, A.B.: Causes and pathogenesis of focal segmental glomerulosclerosis. Nat. Rev. Nephrol. 11(2), 76\u201387 (2015)","journal-title":"Nat. Rev. Nephrol."},{"key":"2_CR26","first-page":"1027376","volume":"2017","author":"H Shimohata","year":"2017","unstructured":"Shimohata, H., Ohgi, K., Maruyama, H., Miyamoto, Y., Takayashu, M., Hirayama, K., et al.: A case of proliferative glomerulonephritis with monoclonal IgG deposits that showed predominantly membranous features. Case Rep Nephrol. 2017, 1027376 (2017)","journal-title":"Case Rep Nephrol."},{"issue":"4","key":"2_CR27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cnur.2018.07.006","volume":"53","author":"P Orr","year":"2018","unstructured":"Orr, P., Shank, B.C., Hickson, S., Cooke, J.: Clinical management of glomerular diseases. Nurs. Clin. North Am. 53(4), 551\u2013567 (2018)","journal-title":"Nurs. Clin. North Am."},{"issue":"5","key":"2_CR28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1053\/j.ajkd.2009.04.016","volume":"54","author":"N Stoycheff","year":"2009","unstructured":"Stoycheff, N., Stevens, L.A., Schmid, C.H., Tighiouart, H., Lewis, J., Atkins, R.C., et al.: Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition. Am. J. Kidney Dis. 54(5), 840\u2013849 (2009)","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"2_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archinte.161.1.25","volume":"161","author":"MP Madaio","year":"2001","unstructured":"Madaio, M.P., Harrington, J.T.: The diagnosis of glomerular diseases: acute glomerulonephritis and the nephrotic syndrome. Arch. Intern. Med. 161(1), 25\u201334 (2001)","journal-title":"Arch. Intern. Med."},{"key":"2_CR30","doi-asserted-by":"publisher","unstructured":"Levey, A.S., de Jong, P.E., Coresh, J., El Nahas, M., Astor, B.C., Matsushita, K., et al.: The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 80(1), 17\u201328 (2011 July). https:\/\/doi.org\/10.1038\/ki.2010.483. Epub 2010. Dec 8","DOI":"10.1038\/ki.2010.483"},{"issue":"6968","key":"2_CR31","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1136\/bmj.309.6968.1557","volume":"309","author":"PD Mason","year":"1994","unstructured":"Mason, P.D., Pusey, C.D.: Glomerulonephritis: diagnosis and treatment. BMJ. 309(6968), 1557\u20131563 (1994)","journal-title":"BMJ"},{"key":"2_CR32","doi-asserted-by":"crossref","unstructured":"Beck, L.H., Salant, D.J.: Glomerular and tubulointerstitial diseases. Prim. Care. 35(2), 265\u2013296, vi (2008)","DOI":"10.1016\/j.pop.2008.01.002"},{"key":"2_CR33","unstructured":"Ferretti, J.J., Stevens, D.L., Fischetti, V.A.: Basic Biology to Clinical Manifestations. 2016"},{"issue":"8","key":"2_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrneph.2017.85","volume":"13","author":"F Yu","year":"2017","unstructured":"Yu, F., Haas, M., Glassock, R., Zhao, M.H.: Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat. Rev. Nephrol. 13(8), 483\u2013495 (2017)","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"2_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.127.1.1","volume":"127","author":"CG Becker","year":"1968","unstructured":"Becker, C.G., Murphy, G.E.: The experimental induction of glomerulonephritis like that in man by infection with group A streptococci. J. Exp. Med. 127(1), 1\u201324 (1968)","journal-title":"J. Exp. Med."},{"issue":"3","key":"2_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archderm.1990.01670270101017","volume":"126","author":"J Kanitakis","year":"1990","unstructured":"Kanitakis, J., Thivolet, J.: Cyclosporine. An immunosuppressant affecting epithelial cell proliferation. Arch. Dermatol. 126(3), 369\u2013375 (1990)","journal-title":"Arch. Dermatol."},{"issue":"1","key":"2_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00041552-200301000-00005","volume":"12","author":"HY Lan","year":"2003","unstructured":"Lan, H.Y.: Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr. Opin. Nephrol. Hypertens. 12(1), 25\u201329 (2003)","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"2_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5935\/0101-2800.20140012","volume":"36","author":"GM Kirsztajn","year":"2014","unstructured":"Kirsztajn, G.M., Filho, N.S., Draibe, S.A., Netto, M.V., Thom\u00e9, F.S., Souza, E., et al.: Fast reading of the KDIGO 2012: guidelines for evaluation and management of chronic kidney disease in clinical practice. J. Bras. Nefrol. 36(1), 63\u201373 (2014)","journal-title":"J. Bras. Nefrol."},{"issue":"3","key":"2_CR39","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ndt\/gfx016","volume":"32","author":"C Ronco","year":"2017","unstructured":"Ronco, C., Rizo-Topete, L., Serrano-Soto, M., Kashani, K.: Pro: prevention of acute kidney injury: time for teamwork and new biomarkers. Nephrol. Dial. Transplant. 32(3), 408\u2013413 (2017)","journal-title":"Nephrol. Dial. Transplant."},{"issue":"10212","key":"2_CR40","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","volume":"394","author":"C Ronco","year":"2019","unstructured":"Ronco, C., Bellomo, R., Kellum, J.A.: Acute kidney injury. Lancet. 394(10212), 1949\u20131964 (2019)","journal-title":"Lancet"},{"issue":"10","key":"2_CR41","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41581-019-0184-x","volume":"15","author":"B Desanti De Oliveira","year":"2019","unstructured":"Desanti De Oliveira, B., Xu, K., Shen, T.H., Callahan, M., Kiryluk, K., D\u2019Agati, V.D., et al.: Molecular nephrology: types of acute tubular injury. Nat. Rev. Nephrol. 15(10), 599\u2013612 (2019)","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"2_CR42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/nep.13408","volume":"23","author":"D Rangaswamy","year":"2018","unstructured":"Rangaswamy, D., Sud, K.: Acute kidney injury and disease: long-term consequences and management. Nephrology (Carlton). 23(11), 969\u2013980 (2018)","journal-title":"Nephrology (Carlton)"},{"key":"2_CR43","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1\u2013266"},{"key":"2_CR44","first-page":"7","volume":"7","author":"I Section","year":"2002","unstructured":"Section, I.: Measurement of renal function, when to refer and when to start dialysis. Nephrol. Dial. Transplant. 7, 7\u201315 (2002)","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3 Suppl 1","key":"2_CR45","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/ajkd.2003.50074","volume":"41","author":"S Klahr","year":"2003","unstructured":"Klahr, S., Morrissey, J.: Progression of chronic renal disease. Am. J. Kidney Dis. 41(3 Suppl 1), S3\u2013S7 (2003)","journal-title":"Am. J. Kidney Dis."},{"issue":"9811","key":"2_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","volume":"379","author":"AS Levey","year":"2012","unstructured":"Levey, A.S., Coresh, J.: Chronic kidney disease. Lancet. 379(9811), 165\u2013180 (2012)","journal-title":"Lancet"},{"issue":"8","key":"2_CR47","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1373\/clinchem.2018.299073","volume":"65","author":"WG Miller","year":"2019","unstructured":"Miller, W.G., Bachmann, L.M., Delanghe, J.R., Inker, L.A., Jones, G.R.D., Vassalotti, J.A.: Optimal use of biomarkers for chronic kidney disease. Clin. Chem. 65(8), 949\u2013955 (2019)","journal-title":"Clin. Chem."},{"issue":"65","key":"2_CR48","first-page":"015","volume":"16","author":"S Kent","year":"2015","unstructured":"Kent, S., Schlackow, I., Lozano-Kuhne, J., Reith, C., Emberson, J., Haynes, R., et al.: What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? BMC Nephrol. 16(65), 015\u20130054 (2015)","journal-title":"BMC Nephrol."},{"issue":"3","key":"2_CR49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/157488709789957646","volume":"4","author":"KT Woo","year":"2009","unstructured":"Woo, K.T., Wong, K.S., Chan, C.M.: Clinical trials of the past decade in the management of chronic kidney disease. Rev. Recent Clin. Trials. 4(3), 159\u2013162 (2009)","journal-title":"Rev. Recent Clin. Trials"},{"issue":"4","key":"2_CR50","first-page":"104","volume":"57","author":"P Kujal","year":"2008","unstructured":"Kujal, P., Vernerova, Z.: 5\/6 nephrectomy as an experimental model of chronic renal failure and adaptation to reduced nephron number. Cesk. Fysiol. 57(4), 104\u2013109 (2008)","journal-title":"Cesk. Fysiol."},{"issue":"4","key":"2_CR51","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/j.1523-1755.2000.00327.x","volume":"58","author":"MW Taal","year":"2000","unstructured":"Taal, M.W., Zandi-Nejad, K., Weening, B., Shahsafaei, A., Kato, S., Lee, K.W., et al.: Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int. 58(4), 1664\u20131676 (2000)","journal-title":"Kidney Int."},{"issue":"2","key":"2_CR52","first-page":"81","volume":"65","author":"M Sasaki","year":"2011","unstructured":"Sasaki, M., Shikata, K., Okada, S., Miyamoto, S., Nishishita, S., Kataoka, H.U., et al.: The macrophage is a key factor in renal injuries caused by glomerular hyperfiltration. Acta Med Okayama. 65(2), 81\u201389 (2011)","journal-title":"Acta Med Okayama"},{"issue":"7","key":"2_CR53","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/sj.ki.5000060","volume":"69","author":"A Remuzzi","year":"2006","unstructured":"Remuzzi, A., Gagliardini, E., Sangalli, F., Bonomelli, M., Piccinelli, M., Benigni, A., et al.: ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int. 69(7), 1124\u20131130 (2006)","journal-title":"Kidney Int."},{"issue":"4","key":"2_CR54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2302\/kjm.36.369","volume":"36","author":"Y Yoshida","year":"1987","unstructured":"Yoshida, Y., Fogo, A., Glick, A.D., Ichikawa, I.: Biology of progression of chronic renal diseases. Keio J. Med. 36(4), 369\u2013380 (1987)","journal-title":"Keio J. Med."},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000414791","volume":"60","author":"R Waldherr","year":"1988","unstructured":"Waldherr, R., Gretz, N.: Natural course of the development of histological lesions after 5\/6 nephrectomy. Contrib. Nephrol. 60, 64\u201372 (1988)","journal-title":"Contrib. Nephrol."},{"issue":"4","key":"2_CR56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/14764170802524403","volume":"10","author":"C Romero","year":"2008","unstructured":"Romero, C., Caballero, N., Herrero, M., Ru\u00edz, R., Sadick, N.S., Trelles, M.A.: Effects of cellulite treatment with RF, IR light, mechanical massage and suction treating one buttock with the contralateral as a control. J. Cosmet. Laser Ther. 10(4), 193\u2013201 (2008)","journal-title":"J. Cosmet. Laser Ther."},{"issue":"11","key":"2_CR57","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.2337\/dc10-1580","volume":"33","author":"P Romero-Aroca","year":"2010","unstructured":"Romero-Aroca, P.: Targeting the pathophysiology of diabetic macular edema. Diabetes Care. 33(11), 2484\u20132485 (2010)","journal-title":"Diabetes Care"},{"issue":"1","key":"2_CR58","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12882-018-0821-9","volume":"19","author":"KC Norris","year":"2018","unstructured":"Norris, K.C., Smoyer, K.E., Rolland, C., Van der Vaart, J., Grubb, E.B.: Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review. BMC Nephrol. 19(1), 36 (2018)","journal-title":"BMC Nephrol."},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"2852398","DOI":"10.1155\/2018\/2852398","volume":"2018","author":"B Satirapoj","year":"2018","unstructured":"Satirapoj, B.: Tubulointerstitial biomarkers for diabetic nephropathy. J. Diabetes Res. 2018, 2852398 (2018)","journal-title":"J. Diabetes Res."},{"issue":"3","key":"2_CR60","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/0929867324666170509145240","volume":"25","author":"O Karmin","year":"2018","unstructured":"Karmin, O., Siow, Y.L.: Metabolic imbalance of homocysteine and hydrogen sulfide in kidney disease. Curr. Med. Chem. 25(3), 367\u2013377 (2018)","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"2_CR61","first-page":"78","volume":"50","author":"SV Villeval\u2019de","year":"2010","unstructured":"Villeval\u2019de, S.V., Gudgalis, N.I., Kobalava, Z.D.: Cistatin C as a novel marker of renal function impairement and cardiovascular risk. Kardiologiia. 50(6), 78\u201382 (2010)","journal-title":"Kardiologiia"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"7659243","DOI":"10.1155\/2018\/7659243","volume":"2018","author":"A \u017by\u0142ka","year":"2018","unstructured":"\u017by\u0142ka, A., Dumnicka, P., Ku\u015bnierz-Cabala, B., Gala-B\u0142\u0105dzi\u0144ska, A., Ceranowicz, P., Kucharz, J., et al.: Markers of glomerular and tubular damage in the early stage of kidney disease in type 2 diabetic patients. Mediat. Inflamm. 2018, 7659243 (2018)","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"2_CR63","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1373\/jalm.2018.028530","volume":"4","author":"GV Kapoula","year":"2019","unstructured":"Kapoula, G.V., Kontou, P.I., Bagos, P.G.: Diagnostic accuracy of neutrophil gelatinase-associated Lipocalin for predicting early diabetic nephropathy in patients with type 1 and type 2 diabetes mellitus: a systematic review and meta-analysis. J Appl Lab Med. 4(1), 78\u201394 (2019)","journal-title":"J Appl Lab Med."},{"issue":"3","key":"2_CR64","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2337\/dc16-2202","volume":"40","author":"G Mayer","year":"2017","unstructured":"Mayer, G., Heerspink, H.J., Aschauer, C., Heinzel, A., Heinze, G., Kainz, A., et al.: Systems biology-derived biomarkers to predict progression of renal function decline in type 2 diabetes. Diabetes Care. 40(3), 391\u2013397 (2017)","journal-title":"Diabetes Care"},{"issue":"4","key":"2_CR65","doi-asserted-by":"publisher","first-page":"e22830","DOI":"10.1002\/jcla.22830","volume":"33","author":"YT Lai","year":"2019","unstructured":"Lai, Y.T., Cerquinho, R.G., Perez, M.M., Alves, B.D.C.A., Pereira, E.C., Azzalis, L.A., et al.: Determination of vitamin D in tears of healthy individuals by the electrochemiluminescence method. J. Clin. Lab. Anal. 33(4), e22830 (2019)","journal-title":"J. Clin. Lab. Anal."},{"key":"2_CR66","doi-asserted-by":"crossref","unstructured":"Luz, M.C., Perez, M.M., Azzalis, L.A., Sousa, L.V., Adami, F., Fonseca, F.L., et al.: Evaluation of MCT1, MCT4 and CD147 genes in peripheral blood cells of breast cancer patients and their potential use as diagnostic and prognostic markers. Int. J. Mol. Sci. 18(4) (2017)","DOI":"10.3390\/ijms18040170"},{"issue":"2","key":"2_CR67","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bib\/bbw114","volume":"19","author":"C Manzoni","year":"2018","unstructured":"Manzoni, C., Kia, D.A., Vandrovcova, J., Hardy, J., Wood, N.W., Lewis, P.A., et al.: Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief. Bioinform. 19(2), 286\u2013302 (2018)","journal-title":"Brief. Bioinform."},{"issue":"2","key":"2_CR68","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/mas.21455","volume":"36","author":"MM Khamis","year":"2017","unstructured":"Khamis, M.M., Adamko, D.J., El-Aneed, A.: Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Mass Spectrom. Rev. 36(2), 115\u2013134 (2017)","journal-title":"Mass Spectrom. Rev."},{"issue":"10","key":"2_CR69","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/jnci\/96.10.732","volume":"96","author":"C Schmidt","year":"2004","unstructured":"Schmidt, C.: Metabolomics takes its place as latest up-and-coming \u201comic\u201d science. J. Natl. Cancer Inst. 96(10), 732\u2013734 (2004)","journal-title":"J. Natl. Cancer Inst."},{"issue":"Database issue","key":"2_CR70","first-page":"D801","volume":"41","author":"DS Wishart","year":"2013","unstructured":"Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., et al.: HMDB 3.0--the human metabolome database in 2013. Nucleic Acids Res. 41(Database issue), D801\u2013D807 (2013)","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2_CR71","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jat.1746","volume":"32","author":"BS Kumar","year":"2012","unstructured":"Kumar, B.S., Chung, B.C., Kwon, O.S., Jung, B.H.: Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics. J. Appl. Toxicol. 32(7), 505\u2013520 (2012)","journal-title":"J. Appl. Toxicol."},{"issue":"8","key":"2_CR72","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1681\/ASN.2012101006","volume":"24","author":"EP Rhee","year":"2013","unstructured":"Rhee, E.P., Clish, C.B., Ghorbani, A., Larson, M.G., Elmariah, S., McCabe, E., et al.: A combined epidemiologic and metabolomic approach improves CKD prediction. J. Am. Soc. Nephrol. 24(8), 1330\u20131338 (2013)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"2_CR73","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1681\/ASN.2013020126","volume":"24","author":"K Sharma","year":"2013","unstructured":"Sharma, K., Karl, B., Mathew, A.V., Gangoiti, J.A., Wassel, C.L., Saito, R., et al.: Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J. Am. Soc. Nephrol. 24(11), 1901\u20131912 (2013)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"22","key":"2_CR74","doi-asserted-by":"publisher","first-page":"11033","DOI":"10.1093\/nar\/gkw880","volume":"44","author":"JA Vizca\u00edno","year":"2016","unstructured":"Vizca\u00edno, J.A., Csordas, A., Del-Toro, N., Dianes, J.A., Griss, J., Lavidas, I., et al.: 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44(22), 11033 (2016)","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"2_CR75","first-page":"2079","volume":"32","author":"J Siwy","year":"2017","unstructured":"Siwy, J., Z\u00fcrbig, P., Argiles, A., Beige, J., Haubitz, M., Jankowski, J., et al.: Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis. Nephrol. Dial. Transplant. 32(12), 2079\u20132089 (2017)","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7011","key":"2_CR76","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature03001","volume":"431","author":"IHGS Consortium","year":"2004","unstructured":"Consortium, I.H.G.S.: Finishing the euchromatic sequence of the human genome. Nature. 431(7011), 931\u2013945 (2004)","journal-title":"Nature"},{"issue":"9","key":"2_CR77","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1101\/gr.135350.111","volume":"22","author":"J Harrow","year":"2012","unstructured":"Harrow, J., Frankish, A., Gonzalez, J.M., Tapanari, E., Diekhans, M., Kokocinski, F., et al.: GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22(9), 1760\u20131774 (2012)","journal-title":"Genome Res."},{"issue":"3","key":"2_CR78","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1590\/S0102-311X2002000300001","volume":"18","author":"PM Buss","year":"2002","unstructured":"Buss, P.M.: Genomics and public health. Cad. Saude Publica. 18(3), 554\u2013555 (2002)","journal-title":"Cad. Saude Publica"},{"issue":"2","key":"2_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrneph.2017.167","volume":"14","author":"EE Groopman","year":"2018","unstructured":"Groopman, E.E., Rasouly, H.M., Gharavi, A.G.: Genomic medicine for kidney disease. Nat. Rev. Nephrol. 14(2), 83\u2013104 (2018)","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"2_CR80","doi-asserted-by":"publisher","first-page":"e0190280","DOI":"10.1371\/journal.pone.0190280","volume":"13","author":"A Lecamwasam","year":"2018","unstructured":"Lecamwasam, A., Sexton-Oates, A., Carmody, J., Ekinci, E.I., Dwyer, K.M., Saffery, R.: DNA methylation profiling of genomic DNA isolated from urine in diabetic chronic kidney disease: a pilot study. PLoS One. 13(2), e0190280 (2018)","journal-title":"PLoS One"},{"issue":"9","key":"2_CR81","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1080\/0886022X.2016.1227918","volume":"38","author":"S Sadar","year":"2016","unstructured":"Sadar, S., Kaspate, D., Vyawahare, N.: Protective effect of L-glutamine against diabetes-induced nephropathy in experimental animal: role of KIM-1, NGAL, TGF-\u03b21, and collagen-1. Ren Fail. 38(9), 1483\u20131495 (2016)","journal-title":"Ren Fail"},{"issue":"1","key":"2_CR82","doi-asserted-by":"publisher","first-page":"e0148043","DOI":"10.1371\/journal.pone.0148043","volume":"11","author":"T Kaucs\u00e1r","year":"2016","unstructured":"Kaucs\u00e1r, T., God\u00f3, M., R\u00e9v\u00e9sz, C., Kov\u00e1cs, M., M\u00f3csai, A., Kiss, N., et al.: Urine\/plasma neutrophil gelatinase associated lipocalin ratio is a sensitive and specific marker of subclinical acute kidney injury in mice. PLoS One. 11(1), e0148043 (2016)","journal-title":"PLoS One"},{"issue":"3","key":"2_CR83","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1155\/2013\/349545","volume":"34","author":"CC Luk","year":"2013","unstructured":"Luk, C.C., Chow, K.M., Kwok, J.S., Kwan, B.C., Chan, M.H., Lai, K.B., et al.: Urinary biomarkers for the prediction of reversibility in acute-on-chronic renal failure. Dis. Markers. 34(3), 179\u2013185 (2013)","journal-title":"Dis. Markers"},{"issue":"8","key":"2_CR84","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/00004872-199408000-00007","volume":"12","author":"C Hemmingsen","year":"1994","unstructured":"Hemmingsen, C., Staun, M., Lewin, E., Egfjord, M., Olgaard, K.: Calcium metabolic changes and calbindin-D in experimental hypertension. J. Hypertens. 12(8), 901\u2013907 (1994)","journal-title":"J. Hypertens."},{"issue":"3 Pt 2","key":"2_CR85","first-page":"F477","volume":"266","author":"R Kumar","year":"1994","unstructured":"Kumar, R., Schaefer, J., Grande, J.P., Roche, P.C.: Immunolocalization of calcitriol receptor, 24-hydroxylase cytochrome P-450, and calbindin D28k in human kidney. Am. J. Phys. 266(3 Pt 2), F477\u2013F485 (1994)","journal-title":"Am. J. Phys."},{"issue":"2","key":"2_CR86","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/toxsci\/kfr013","volume":"120","author":"M Guha","year":"2011","unstructured":"Guha, M., Heier, A., Price, S., Bielenstein, M., Caccese, R.G., Heathcote, D.I., et al.: Assessment of biomarkers of drug-induced kidney injury in cynomolgus monkeys treated with a triple reuptake inhibitor. Toxicol. Sci. 120(2), 269\u2013283 (2011)","journal-title":"Toxicol. Sci."},{"issue":"Pt 2","key":"2_CR87","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/bj3440375","volume":"344","author":"M Calero","year":"1999","unstructured":"Calero, M., Tokuda, T., Rostagno, A., Kumar, A., Zlokovic, B., Frangione, B., et al.: Functional and structural properties of lipid-associated apolipoprotein J (clusterin). Biochem. J. 344(Pt 2), 375\u2013383 (1999)","journal-title":"Biochem. J."},{"issue":"3","key":"2_CR88","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0006-291X(91)90635-K","volume":"177","author":"MR Wilson","year":"1991","unstructured":"Wilson, M.R., Roeth, P.J., Easterbrook-Smith, S.B.: Clusterin enhances the formation of insoluble immune complexes. Biochem. Biophys. Res. Commun. 177(3), 985\u2013990 (1991)","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"2_CR89","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1523-1747.1999.00531.x","volume":"112","author":"I Viard","year":"1999","unstructured":"Viard, I., Wehrli, P., Jornot, L., Bullani, R., Vechietti, J.L., Schifferli, J.A., et al.: Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J. Invest. Dermatol. 112(3), 290\u2013296 (1999)","journal-title":"J. Invest. Dermatol."},{"issue":"13","key":"2_CR90","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M209233200","volume":"278","author":"KS Leskov","year":"2003","unstructured":"Leskov, K.S., Klokov, D.Y., Li, J., Kinsella, T.J., Boothman, D.A.: Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278(13), 11590\u201311600 (2003)","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2_CR91","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1081\/JDI-120016063","volume":"24","author":"X Xu","year":"2002","unstructured":"Xu, X., Wu, Z., Zhou, Q., Zhang, Y., Wu, D.: The role of determining the levels of serum collagen type IV in diagnosing early diabetic nephropathy. Ren. Fail. 24(6), 747\u2013753 (2002)","journal-title":"Ren. Fail."},{"issue":"9402","key":"2_CR92","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0140-6736(03)15172-0","volume":"363","author":"B Perbal","year":"2004","unstructured":"Perbal, B.: CCN proteins: multifunctional signalling regulators. Lancet. 363(9402), 62\u201364 (2004)","journal-title":"Lancet"},{"issue":"1","key":"2_CR93","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/1516-3180.2016.0099220516","volume":"135","author":"O Mosa","year":"2017","unstructured":"Mosa, O., Skitek, M., Jerin, A.: Validity of Klotho, CYR61 and YKL-40 as ideal predictive biomarkers for acute kidney injury: review study. Sao Paulo Med. J. 135(1), 57\u201365 (2017)","journal-title":"Sao Paulo Med. J."},{"issue":"4","key":"2_CR94","doi-asserted-by":"publisher","first-page":"F1363","DOI":"10.1152\/ajprenal.00205.2007","volume":"293","author":"K Sawai","year":"2007","unstructured":"Sawai, K., Mukoyama, M., Mori, K., Kasahara, M., Koshikawa, M., Yokoi, H., et al.: Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney. Am. J. Physiol. Renal Physiol. 293(4), F1363\u2013F1372 (2007)","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"2_CR95","doi-asserted-by":"publisher","first-page":"F581","DOI":"10.1152\/ajprenal.00670.2013","volume":"307","author":"CF Lai","year":"2014","unstructured":"Lai, C.F., Lin, S.L., Chiang, W.C., Chen, Y.M., Wu, V.C., Young, G.H., et al.: Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury. Am. J. Physiol. Renal Physiol. 307(5), F581\u2013F592 (2014)","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"2_CR96","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11255-017-1740-6","volume":"50","author":"O Ulutas","year":"2018","unstructured":"Ulutas, O., Taskapan, M.C., Dogan, A., Baysal, T., Taskapan, H.: Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients. Int. Urol. Nephrol. 50(1), 137\u2013142 (2018)","journal-title":"Int. Urol. Nephrol."},{"issue":"6","key":"2_CR97","doi-asserted-by":"publisher","first-page":"F751","DOI":"10.1152\/ajprenal.00329.2012","volume":"304","author":"I Matsui","year":"2013","unstructured":"Matsui, I., Hamano, T., Mikami, S., Inoue, K., Shimomura, A., Nagasawa, Y., et al.: Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats. Am. J. Physiol. Renal Physiol. 304(6), F751\u2013F760 (2013)","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"2_CR98","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1681\/ASN.2008060572","volume":"20","author":"R Westenfeld","year":"2009","unstructured":"Westenfeld, R., Sch\u00e4fer, C., Kr\u00fcger, T., Haarmann, C., Schurgers, L.J., Reutelingsperger, C., et al.: Fetuin-A protects against atherosclerotic calcification in CKD. J. Am. Soc. Nephrol. 20(6), 1264\u20131274 (2009)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"2_CR99","first-page":"394","volume":"70","author":"A Mehrsai","year":"2017","unstructured":"Mehrsai, A., Guitynavard, F., Nikoobakht, M.R., Gooran, S., Ahmadi, A.: The relationship between serum and urinary Fetuin-A levels and kidney stone formation among kidney stone patients. Cent European J Urol. 70(4), 394\u2013399 (2017)","journal-title":"Cent European J Urol."},{"issue":"9","key":"2_CR100","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1464-410X.2007.07432.x","volume":"101","author":"D Stejskal","year":"2008","unstructured":"Stejskal, D., Karpisek, M., Vrtal, R., Student, V., Solichova, P., Fiala, R., et al.: Urine fetuin-A values in relation to the presence of urolithiasis. BJU Int. 101(9), 1151\u20131154 (2008)","journal-title":"BJU Int."},{"key":"2_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2016.12.001","volume":"39","author":"M Andreucci","year":"2017","unstructured":"Andreucci, M., Faga, T., Pisani, A., Perticone, M., Michael, A.: The ischemic\/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice. Eur. J. Intern. Med. 39, 1\u20138 (2017)","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"2_CR102","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12872-016-0340-1","volume":"16","author":"A Shirakabe","year":"2016","unstructured":"Shirakabe, A., Kobayashi, N., Hata, N., Shinada, T., Tomita, K., Tsurumi, M., et al.: The serum heart-type fatty acid-binding protein (HFABP) levels can be used to detect the presence of acute kidney injury on admission in patients admitted to the non-surgical intensive care unit. BMC Cardiovasc. Disord. 16(1), 174 (2016)","journal-title":"BMC Cardiovasc. Disord."},{"issue":"5","key":"2_CR103","first-page":"628","volume":"34","author":"M Kokot","year":"2014","unstructured":"Kokot, M., Biolik, G., Ziaja, D., Fojt, T., K\u0119dzierski, L., Antoniak, K., et al.: Assessment of subclinical acute kidney injury after abdominal aortic aneurysm surgery using novel markers: L-FABP and H-FABP. Nefrologia. 34(5), 628\u2013636 (2014)","journal-title":"Nefrologia"},{"issue":"5","key":"2_CR104","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00240-015-0793-1","volume":"43","author":"N Ozturk","year":"2015","unstructured":"Ozturk, N., Aksoy, H., Aksoy, Y., Yildirim, A., Akcay, F., Yanmaz, V.: The low levels of circulating hepatocyte growth factor in nephrolithiasis cases: independent from gene polymorphism. Urolithiasis. 43(5), 427\u2013432 (2015)","journal-title":"Urolithiasis"},{"issue":"1","key":"2_CR105","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/01.HYP.0000046919.41112.4B","volume":"41","author":"LS Malatino","year":"2003","unstructured":"Malatino, L.S., Cataliotti, A., Benedetto, F.A., Stancanelli, B., Bellanuova, I., Belluardo, P., et al.: Hepatocyte growth factor and left ventricular geometry in end-stage renal disease. Hypertension. 41(1), 88\u201392 (2003)","journal-title":"Hypertension"},{"key":"2_CR106","doi-asserted-by":"crossref","unstructured":"Cho, W.Y., Lim, S.Y., Yang, J.H., Oh, S.W., Kim, M.G., Jo, S.K.: Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 as biomarkers of patients with established acute kidney injury. Korean J. Intern. Med. (2019)","DOI":"10.3904\/kjim.2018.266"},{"issue":"3","key":"2_CR107","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1053\/j.ajkd.2003.10.040","volume":"43","author":"CR Parikh","year":"2004","unstructured":"Parikh, C.R., Jani, A., Melnikov, V.Y., Faubel, S., Edelstein, C.L.: Urinary interleukin-18 is a marker of human acute tubular necrosis. Am. J. Kidney Dis. 43(3), 405\u2013414 (2004)","journal-title":"Am. J. Kidney Dis."},{"key":"2_CR108","doi-asserted-by":"crossref","unstructured":"Milas, O., Gadalean, F., Vlad, A., Dumitrascu, V., Velciov, S., Gluhovschi, C., et al.: Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients. J. Diabetes Complicat., 107479 (2019)","DOI":"10.1016\/j.jdiacomp.2019.107479"},{"issue":"5","key":"2_CR109","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1172\/JCI34487","volume":"118","author":"T Ichimura","year":"2008","unstructured":"Ichimura, T., Asseldonk, E.J., Humphreys, B.D., Gunaratnam, L., Duffield, J.S., Bonventre, J.V.: Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118(5), 1657\u20131668 (2008)","journal-title":"J. Clin. Invest."},{"issue":"1","key":"2_CR110","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","volume":"62","author":"WK Han","year":"2002","unstructured":"Han, W.K., Bailly, V., Abichandani, R., Thadhani, R., Bonventre, J.V.: Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62(1), 237\u2013244 (2002)","journal-title":"Kidney Int."},{"issue":"11","key":"2_CR111","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrneph.2013.194","volume":"9","author":"KRR fibrosis","year":"2013","unstructured":"fibrosis, K.R.R.: KIM-1 expression links kidney injury with CKD in mice. Nat. Rev. Nephrol. 9(11), 627 (2013)","journal-title":"Nat. Rev. Nephrol."},{"issue":"10","key":"2_CR112","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1681\/ASN.2013070758","volume":"25","author":"VS Sabbisetti","year":"2014","unstructured":"Sabbisetti, V.S., Waikar, S.S., Antoine, D.J., Smiles, A., Wang, C., Ravisankar, A., et al.: Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J. Am. Soc. Nephrol. 25(10), 2177\u20132186 (2014)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"2_CR113","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0002-9440(10)63384-6","volume":"165","author":"A Kamijo","year":"2004","unstructured":"Kamijo, A., Sugaya, T., Hikawa, A., Okada, M., Okumura, F., Yamanouchi, M., et al.: Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am. J. Pathol. 165(4), 1243\u20131255 (2004)","journal-title":"Am. J. Pathol."},{"issue":"11","key":"2_CR114","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1681\/ASN.2007010097","volume":"18","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto, T., Noiri, E., Ono, Y., Doi, K., Negishi, K., Kamijo, A., et al.: Renal L-type fatty acid--binding protein in acute ischemic injury. J. Am. Soc. Nephrol. 18(11), 2894\u20132902 (2007)","journal-title":"J. Am. Soc. Nephrol."},{"key":"2_CR115","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cca.2015.03.017","volume":"445","author":"Y Xu","year":"2015","unstructured":"Xu, Y., Xie, Y., Shao, X., Ni, Z., Mou, S.: L-FABP: a novel biomarker of kidney disease. Clin. Chim. Acta. 445, 85\u201390 (2015)","journal-title":"Clin. Chim. Acta"},{"key":"2_CR116","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40200-015-0133-6","volume":"14","author":"G Sheira","year":"2015","unstructured":"Sheira, G., Noreldin, N., Tamer, A., Saad, M.: Urinary biomarker N-acetyl-\u03b2-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy. J. Diabetes Metab. Disord. 14, 4 (2015)","journal-title":"J. Diabetes Metab. Disord."},{"issue":"11","key":"2_CR117","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/ndt\/17.11.1890","volume":"17","author":"C Bazzi","year":"2002","unstructured":"Bazzi, C., Petrini, C., Rizza, V., Arrigo, G., Napodano, P., Paparella, M., et al.: Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol. Dial. Transplant. 17(11), 1890\u20131896 (2002)","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"2_CR118","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1681\/ASN.2006030221","volume":"18","author":"O Liangos","year":"2007","unstructured":"Liangos, O., Perianayagam, M.C., Vaidya, V.S., Han, W.K., Wald, R., Tighiouart, H., et al.: Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J. Am. Soc. Nephrol. 18(3), 904\u2013912 (2007)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"2_CR119","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrm2142","volume":"8","author":"V Cirulli","year":"2007","unstructured":"Cirulli, V., Yebra, M.: Netrins: beyond the brain. Nat. Rev. Mol. Cell Biol. 8(4), 296\u2013306 (2007)","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"2_CR120","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2215\/CJN.05140709","volume":"5","author":"G Ramesh","year":"2010","unstructured":"Ramesh, G., Krawczeski, C.D., Woo, J.G., Wang, Y., Devarajan, P.: Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin. J. Am. Soc. Nephrol. 5(3), 395\u2013401 (2010)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"2_CR121","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40620-014-0055-2","volume":"27","author":"C Jayakumar","year":"2014","unstructured":"Jayakumar, C., Nauta, F.L., Bakker, S.J., Bilo, H., Gansevoort, R.T., Johnson, M.H., et al.: Netrin-1, a urinary proximal tubular injury marker, is elevated early in the time course of human diabetes. J. Nephrol. 27(2), 151\u2013157 (2014)","journal-title":"J. Nephrol."},{"issue":"1","key":"2_CR122","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1006\/jmbi.1999.2755","volume":"289","author":"M Coles","year":"1999","unstructured":"Coles, M., Diercks, T., Muehlenweg, B., Bartsch, S., Z\u00f6lzer, V., Tschesche, H., et al.: The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin. J. Mol. Biol. 289(1), 139\u2013157 (1999)","journal-title":"J. Mol. Biol."},{"issue":"1","key":"2_CR123","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.str.2004.10.009","volume":"13","author":"MA Holmes","year":"2005","unstructured":"Holmes, M.A., Paulsene, W., Jide, X., Ratledge, C., Strong, R.K.: Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure. 13(1), 29\u201341 (2005)","journal-title":"Structure"},{"issue":"11","key":"2_CR124","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1172\/JCI42004","volume":"120","author":"A Viau","year":"2010","unstructured":"Viau, A., El Karoui, K., Laouari, D., Burtin, M., Nguyen, C., Mori, K., et al.: Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J. Clin. Invest. 120(11), 4065\u20134076 (2010)","journal-title":"J. Clin. Invest."},{"issue":"12","key":"2_CR125","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.2215\/CJN.00740110","volume":"5","author":"JL Koyner","year":"2010","unstructured":"Koyner, J.L., Vaidya, V.S., Bennett, M.R., Ma, Q., Worcester, E., Akhter, S.A., et al.: Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin. J. Am. Soc. Nephrol. 5(12), 2154\u20132165 (2010)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"12","key":"2_CR126","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.4065\/75.12.1236","volume":"75","author":"WK Lau","year":"2000","unstructured":"Lau, W.K., Blute, M.L., Weaver, A.L., Torres, V.E., Zincke, H.: Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin. Proc. 75(12), 1236\u20131242 (2000)","journal-title":"Mayo Clin. Proc."},{"issue":"8","key":"2_CR127","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ki.2011.198","volume":"80","author":"RG Fassett","year":"2011","unstructured":"Fassett, R.G., Venuthurupalli, S.K., Gobe, G.C., Coombes, J.S., Cooper, M.A., Hoy, W.E.: Biomarkers in chronic kidney disease: a review. Kidney Int. 80(8), 806\u2013821 (2011)","journal-title":"Kidney Int."},{"issue":"3","key":"2_CR128","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0272-6386(03)00744-3","volume":"42","author":"D du Cheyron","year":"2003","unstructured":"du Cheyron, D., Daubin, C., Poggioli, J., Ramakers, M., Houillier, P., Charbonneau, P., et al.: Urinary measurement of Na+\/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am. J. Kidney Dis. 42(3), 497\u2013506 (2003)","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"2_CR129","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00011-018-1200-5","volume":"68","author":"B Kaleta","year":"2019","unstructured":"Kaleta, B.: The role of osteopontin in kidney diseases. Inflamm. Res. 68(2), 93\u2013102 (2019)","journal-title":"Inflamm. Res."},{"key":"2_CR130","doi-asserted-by":"crossref","unstructured":"Kaleta, B., Krata, N., Zago\u017cd\u017con, R., Mucha, K.: Osteopontin gene polymorphism and urinary OPN excretion in patients with immunoglobulin a nephropathy. Cell. 8(6) (2019)","DOI":"10.3390\/cells8060524"},{"key":"2_CR131","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.cca.2014.08.039","volume":"438","author":"ME Wasung","year":"2015","unstructured":"Wasung, M.E., Chawla, L.S., Madero, M.: Biomarkers of renal function, which and when? Clin. Chim. Acta. 438, 350\u2013357 (2015)","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"2_CR132","doi-asserted-by":"publisher","first-page":"e0162186","DOI":"10.1371\/journal.pone.0162186","volume":"11","author":"JH Cho","year":"2016","unstructured":"Cho, J.H., Ryu, H.M., Oh, E.J., Yook, J.M., Ahn, J.S., Jung, H.Y., et al.: Alpha1-antitrypsin attenuates renal fibrosis by inhibiting TGF-\u03b21-induced epithelial mesenchymal transition. PLoS One. 11(9), e0162186 (2016)","journal-title":"PLoS One"},{"issue":"10","key":"2_CR133","first-page":"683","volume":"30","author":"MH Weber","year":"1992","unstructured":"Weber, M.H., Verwiebe, R.: Alpha 1-microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction. Eur. J. Clin. Chem. Clin. Biochem. 30(10), 683\u2013691 (1992)","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"issue":"1","key":"2_CR134","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2215\/CJN.03220314","volume":"10","author":"V Jotwani","year":"2015","unstructured":"Jotwani, V., Scherzer, R., Abraham, A., Estrella, M.M., Bennett, M., Cohen, M.H., et al.: Association of urine \u03b11-microglobulin with kidney function decline and mortality in HIV-infected women. Clin. J. Am. Soc. Nephrol. 10(1), 63\u201373 (2015)","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Advances in Experimental Medicine and Biology","Translational Urinomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-63908-2_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T16:05:31Z","timestamp":1675267531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-63908-2_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030639075","9783030639082"],"references-count":134,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-63908-2_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"7 May 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}